Kangji Medical Holdings Limited (FRA:50J)
Germany
· Delayed Price · Currency is EUR 1.000
+0.005 (0.50%)
At close: Nov 11, 2025
Kangji Medical Holdings Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Nov '25 Nov 10, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2017 |
| Market Capitalization | 1,233 | 942 | 985 | 1,184 | 1,115 | 1,983 | Upgrade
|
| Market Cap Growth | 69.29% | -4.31% | -16.87% | 6.25% | -43.78% | - | Upgrade
|
| Enterprise Value | 1,018 | 572 | 654 | 808 | 726 | 1,649 | Upgrade
|
| Last Close Price | 1.00 | 0.72 | 0.61 | 0.72 | 0.63 | 1.13 | Upgrade
|
| PE Ratio | 18.48 | 12.25 | 15.31 | 18.24 | 17.63 | 63.27 | Upgrade
|
| PS Ratio | 9.91 | 7.06 | 8.33 | 11.10 | 11.67 | 30.96 | Upgrade
|
| PB Ratio | 4.00 | 2.71 | 1.96 | 2.35 | 2.47 | 5.39 | Upgrade
|
| P/TBV Ratio | 4.00 | 2.71 | 2.41 | 2.99 | 2.47 | 5.39 | Upgrade
|
| P/FCF Ratio | 21.37 | 14.10 | 22.98 | 35.84 | 19.89 | 77.94 | Upgrade
|
| P/OCF Ratio | 19.30 | 12.71 | 18.26 | 27.34 | 18.48 | 71.65 | Upgrade
|
| EV/Sales Ratio | 8.00 | 4.28 | 5.53 | 7.57 | 7.60 | 25.74 | Upgrade
|
| EV/EBITDA Ratio | 14.32 | 7.68 | 11.03 | 12.94 | 12.27 | 41.25 | Upgrade
|
| EV/EBIT Ratio | 15.07 | 8.00 | 11.58 | 13.36 | 12.55 | 42.24 | Upgrade
|
| EV/FCF Ratio | 17.64 | 8.56 | 15.25 | 24.44 | 12.95 | 64.79 | Upgrade
|
| Debt / Equity Ratio | 0 | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 | Upgrade
|
| Debt / EBITDA Ratio | 0.00 | 0.01 | 0.09 | 0.10 | 0.01 | 0.02 | Upgrade
|
| Debt / FCF Ratio | 0.00 | 0.01 | 0.13 | 0.20 | 0.01 | 0.03 | Upgrade
|
| Asset Turnover | 0.28 | 0.28 | 0.23 | 0.21 | 0.22 | 0.27 | Upgrade
|
| Inventory Turnover | 1.89 | 1.98 | 1.76 | 1.74 | 2.13 | 1.81 | Upgrade
|
| Quick Ratio | 4.84 | 6.19 | 15.29 | 19.55 | 26.57 | 38.03 | Upgrade
|
| Current Ratio | 5.14 | 7.92 | 17.72 | 20.33 | 27.18 | 38.84 | Upgrade
|
| Return on Equity (ROE) | 22.65% | 17.38% | 11.80% | 13.22% | 14.74% | 15.01% | Upgrade
|
| Return on Assets (ROA) | 9.96% | 9.40% | 6.71% | 7.55% | 8.14% | 10.22% | Upgrade
|
| Return on Capital (ROIC) | 14.88% | 10.20% | 7.13% | 7.92% | 8.41% | 11.27% | Upgrade
|
| Return on Capital Employed (ROCE) | 22.60% | 20.30% | 10.90% | 11.60% | 12.80% | 10.60% | Upgrade
|
| Earnings Yield | 5.41% | 8.17% | 6.53% | 5.48% | 5.67% | 1.58% | Upgrade
|
| FCF Yield | 4.68% | 7.09% | 4.35% | 2.79% | 5.03% | 1.28% | Upgrade
|
| Dividend Yield | 2.93% | 4.39% | 8.56% | 3.47% | 3.09% | 0.41% | Upgrade
|
| Payout Ratio | 293.46% | 283.32% | 42.93% | 37.59% | 9.82% | 84.92% | Upgrade
|
| Buyback Yield / Dilution | -0.68% | -0.29% | 2.95% | 1.95% | -27.83% | 6.13% | Upgrade
|
| Total Shareholder Return | 2.25% | 4.10% | 11.51% | 5.42% | -24.74% | 6.54% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.